Markets
local & international
Asia Pacific
Currencies
Commodities
UK
North America
News
latest news
Latest News
Most Viewed
Business
Currencies
Economy
Markets
Property
Technology
Portfolio
analysis & tools
Portfolios
Alerts
Filters
Reports
Watchlists
Help
Products
products & services
Charting
Data Agent
Data Subscriptions
Historical Data
Investment Game
Pricing
Real Edge
Download
Login
Register
Saturday, 20 April 2024
AtriCure Inc.
NASDAQ
ATRC
Summary
|
Chart
|
News
|
History
|
More info..
NASDAQ : ATRC
33.48
14 Oct 22 00:00
Change:
1.66
Open:
35.73
High:
35.99
Ask:
12.62
Volume:
275,200
Change(%):
4.72
Prev:
35.14
Low:
33.40
Bid:
9.67
Avg vol:
0
Latest News
More news...
AtriCure Inc. (ATRC) Expected to Announce Quarterly Sales of $45.77 Million
12:37 | 12/3/18
The Ledger Gazette
AtriCure logo Analysts expect that AtriCure Inc. (NASDAQ:ATRC) will announce sales of $45.77 million for the current fiscal quarter, according to Zacks Investment Research.
more»
AtriCure, Inc. (NasdaqGM:ATRC) vs. Five Prime Therapeutics, Inc. (NasdaqGS ...
13:22 | 11/3/18
Kaplan Herald
Checking in on some valuation rankings, AtriCure, Inc. (NasdaqGM:ATRC) has a Value Composite score of 76. Developed by James O'Shaughnessy, the VC score uses five valuation ratios.
more»
Q1 2018 EPS Estimates for AtriCure Inc. Reduced by Leerink Swann (ATRC)
10:00 | 11/3/18
The Ledger Gazette
AtriCure Inc. (NASDAQ:ATRC) - Investment analysts at Leerink Swann reduced their Q1 2018 earnings estimates for AtriCure in a research report issued to clients and investors on Monday, according to Zacks Investment Research.
more»
AtriCure, Inc. (NasdaqGM:ATRC): What is the Stock Yielding Shareholders?
13:02 | 10/3/18
Danvers Record
The Current Ratio of AtriCure, Inc. (NasdaqGM:ATRC) is 2.58. The Current Ratio is used by investors to determine whether a company can pay short term and long term debts.
more»
Leerink Swann Research Analysts Lower Earnings Estimates for AtriCure Inc. (ATRC)
08:30 | 10/3/18
StockNewsTimes
AtriCure Inc. (NASDAQ:ATRC) - Equities researchers at Leerink Swann cut their Q1 2018 earnings per share estimates for shares of AtriCure in a research note issued to investors on Monday, according to Zacks Investment Research.
more»
Comments
There are currently no comments on this topic.
Be the first person to Add a Comment...
ADD USER TO MY FAVOURITE
Customize your favourite:
Send me an alert when this user publishes new articles.
Add a Comment
You must be a registered user to post a comment:
REGISTER NOW
If you are already registered, please
LOGIN NOW
Add to Watchlist
Add to Portfolio
Add Email Alert
Global Indices
Code
Last
Change
COMP
10,321
328
3.08%
DJI
29,635
404
1.34%
SP500
3,583
87
2.37%
DAX
12,438
82
0.67%
FTSE
7,488
5
0.07%
NI225
22,420
408
1.86%
TWI
67.27
0.00
0.00%
Most Viewed Stories
More news...
No news available...
Currencies
Code
Last
Change
EURUSD
0.9721
0.0055
0.56%
NZDUSD
0.5548
0.0093
1.65%
AUDUSD
0.6194
0.0107
1.70%
NZDAUD
0.8964
0.0010
0.11%
Newsletters
Email Address:
Weekly Newsletter
Daily Market Report
Daily Forex Report
Daily Global Report